Serology testing was done in the majority of cases, with IgM and IgG antibodies mostly found in CAPA patients [52 (82.5%)], followed by CAC patients [11 (19.6%); p < 0.001]. This evidence concerns the gene CD40LG and episodic ataxia type 2.